Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7776775rdf:typepubmed:Citationlld:pubmed
pubmed-article:7776775lifeskim:mentionsumls-concept:C0018821lld:lifeskim
pubmed-article:7776775lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:7776775lifeskim:mentionsumls-concept:C1545588lld:lifeskim
pubmed-article:7776775lifeskim:mentionsumls-concept:C1291208lld:lifeskim
pubmed-article:7776775pubmed:issue8949lld:pubmed
pubmed-article:7776775pubmed:dateCreated1995-7-7lld:pubmed
pubmed-article:7776775pubmed:abstractTextA low myocardial content of alpha-ketoglutarate during heart surgery might aggravate ischaemic injury. 24 men undergoing coronary surgery participated in a randomised controlled study. 28 g alpha-ketoglutarate was added to blood cardioplegia for intermittent antegrade intracoronary perfusion in 13 cases. alpha-ketoglutarate reduced the appearance in blood of the ischaemic markers creatine kinase MB and troponin T (at 4 h after release of aortic cross-clamp; median [95% CI] 49 [37-60] micrograms/L in controls vs 32 [27-37] micrograms/L for creatine kinase MB, 2.0 [1.2-2.8] vs 1.1 [0.8-1.4] micrograms/L for troponin T). These findings signify attenuated ischaemic injury, possibly secondary to enhanced myocardial oxidative capacity.lld:pubmed
pubmed-article:7776775pubmed:languageenglld:pubmed
pubmed-article:7776775pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7776775pubmed:statusMEDLINElld:pubmed
pubmed-article:7776775pubmed:monthMarlld:pubmed
pubmed-article:7776775pubmed:issn0140-6736lld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:JagenburgRRlld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:SvenssonGGlld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:NilssonFFlld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:KarlssonHHlld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:EkrothRRlld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:WernermanJJlld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:BjörkKKlld:pubmed
pubmed-article:7776775pubmed:authorpubmed-author:KjellmanUUlld:pubmed
pubmed-article:7776775pubmed:issnTypePrintlld:pubmed
pubmed-article:7776775pubmed:day4lld:pubmed
pubmed-article:7776775pubmed:volume345lld:pubmed
pubmed-article:7776775pubmed:ownerNLMlld:pubmed
pubmed-article:7776775pubmed:authorsCompleteYlld:pubmed
pubmed-article:7776775pubmed:pagination552-3lld:pubmed
pubmed-article:7776775pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:meshHeadingpubmed-meshheading:7776775-...lld:pubmed
pubmed-article:7776775pubmed:year1995lld:pubmed
pubmed-article:7776775pubmed:articleTitleAlpha-ketoglutarate for myocardial protection in heart surgery.lld:pubmed
pubmed-article:7776775pubmed:affiliationDepartment of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.lld:pubmed
pubmed-article:7776775pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7776775pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7776775pubmed:publicationTypeRandomized Controlled Triallld:pubmed